文献速递肿瘤 PET/CT

多中心间[18F]FDG PET/CT用于非小细胞肺癌治疗后监测的可靠性

Reliability of [18F]FDG PET/CT for post-treatment surveillance of non-small cell lung cancer: agreement among multiple centers.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2025-06-21

研究纳入7个中心9个团队,对150例治疗后6个月的非小细胞肺癌(NSCLC)患者PET/CT独立双盲判读。常规评估观察者间一致性中等(κ=0.55),Hopkins标准达显著一致(κ=0.61);两种方法AUC无差异(0.80 vs 0.82,p=0.21)。

要点

  • 常规评估诊断复发的观察者间一致性为中等(κ=0.55,95%CI 0.41-0.69)。
  • Hopkins标准评估的观察者间一致性为显著(κ=0.61,95%CI 0.45-0.77)。
  • 两种方法AUC无显著差异(0.80 vs 0.82,p=0.21),预设标准未降低诊断准确性。

核心结论

  • NSCLC监测中[18F]FDG PET/CT判读的观察者间一致性为中等至显著。
  • 应用预设报告标准未显著改善一致性,但未妨碍诊断准确性。
  • 减少报告变异性的努力(包括持续培训和结构化报告)可能改善该技术的临床影响。

研究设计与样本

  • 多中心研究,7个中心9个团队参与,每团队由1名核医学专家和1名放射科医生组成。
  • 共选取150例PET/CT扫描,每例由随机分配的两个团队独立判读。
  • 扫描为Ia-IIIc期NSCLC患者治疗后6个月的计划性复发评估。

主要发现

  • 常规评估诊断复发的观察者间一致性为中等(κ=0.55,95%CI 0.41-0.69;总体一致率79%)。
  • Hopkins标准评估的观察者间一致性为显著(κ=0.61,95%CI 0.45-0.77;总体一致率87%)。
  • 常规评估与Hopkins标准相比参考标准的AUC分别为0.80(95%CI 0.72-0.88)和0.82(95%CI 0.74-0.90),差异无统计学意义(p=0.21)。

关键数值与推荐

  • 常规评估:无预设标准的判读方法,观察者间一致性κ=0.55(95%CI 0.41-0.69),总体一致率79%。
  • Hopkins标准:预设定性判读标准,观察者间一致性κ=0.61(95%CI 0.45-0.77),总体一致率87%。
  • 常规评估AUC=0.80(95%CI 0.72-0.88),Hopkins标准AUC=0.82(95%CI 0.74-0.90),p=0.21。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography ([18F]FDG PET/CT) has shown promise for post-treatment surveillance in patients with non-small cell lung cancer (NSCLC). This study evaluated interobserver agreement of PET/CT interpretation for NSCLC surveillance in a multicenter setting. METHODS: Nine teams from seven centers, each team consisting of a nuclear medicine specialist and a radiologist, participated in the study. A total of 150 PET/CT scans were selected, and each was independently reviewed by two randomly assigned teams. Scans were performed six months post-treatment for scheduled recurrence assessment in stage Ia-IIIc NSCLC patients. Each scan was evaluated for suspicion of recurrence using two methods; without any pre-specified criteria (conventional assessment) and using pre-specified, qualitative criteria (Hopkins criteria). Both scoring methods were compared to a reference standard to assess accuracy. RESULTS: Conventional assessment showed moderate interobserver agreement (κ = 0.55, 95% CI 0.41-0.69; 79% overall agreement) for the diagnosis of recurrence. Hopkins criteria demonstrated substantial agreement (κ = 0.61, 95% CI 0.45-0.77; 87% overall agreement). There was no difference in the area under the curve (AUC) between conventional assessment (0.80, 95% CI 0.72-0.88) and Hopkins criteria (0.82, 95% CI 0.74-0.90) compared to the reference standard (p = 0.21). CONCLUSIONS: Interobserver agreement for [18F]FDG PET/CT interpretation in NSCLC surveillance was moderate to substantial. While applying pre-specified reporting criteria did not significantly improve the agreement, it did not hinder the diagnostic accuracy. Efforts to reduce the variability of reporting, including continuous training and structured reporting, could improve the clinical impact of this technology.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Guldbrandsen KF, Lonsdale MN, Nellemann HM, et al. Reliability of [18F]FDG PET/CT for post-treatment surveillance of non-small cell lung cancer: agreement among multiple centers. Eur J Nucl Med Mol Imaging. 2025. PMID: 40542151. doi:10.1007/s00259-025-07420-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。